National Cancer Centre, Singapore

This study is testing whether adding a drug called S-1 to a standard lung cancer medication (osimertinib) can help control cancer that has started growing again. It is for 30 adults with a specific type of advanced lung cancer (EGFR mutant NSCLC) that has become resistant to osim…

This small pilot study is testing whether a trained, non-medical support coordinator can help women with advanced breast cancer have better conversations about their values and goals with their doctors. The coordinator meets with patients to discuss their concerns and priorities,…